H-吴越投资2020-03-04 21:57
春节期间对血液灌流治疗进行初步研究,对采用全血灌流和血浆灌流的产品做了一些疏理,附以我个人的一些理解。相关公司列表如下:
表一、血浆吸附:
注:
(1)血浆吸附模式提前将血液中的血细胞分离出来,吸附效率更佳,还可以避免或减少血液相容性问题。血液相容性可能是因为离子树脂...查看全文
$Cytosorbents(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-11-05 AccNo: 0001104659-19-060053 Size: 5 MB 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-11-06 AccNo: 0001104659-19-060134 Size: 173 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-09-18 AccNo: 0001144204-19-045064 Size: 53 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-09-16 AccNo: 0001144204-19-044743 Size: 3 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2019-08-26 AccNo: 0001144204-19-041664 Size: 244 KB 网页链接
$Cytosorbents(CTSO)$ 内部交易: 2019-08-09,CFO,BLOCH KATHLEEN P. ,买入,1500普通股, $5.52
$Cytosorbents(CTSO)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-06 AccNo: 0001144204-19-037883 Size: 5 MB 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-08-06 AccNo: 0001144204-19-037900 Size: 218 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-08-05 AccNo: 0001144204-19-037670 Size: 363 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial...
$Cytosorbents(CTSO)$ 8-K - Current report Filed: 2019-08-05 AccNo: 0001144204-19-037679 Size: 60 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接